Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.572,07
-0,76%
NASDAQ
17.436,10
-0,18%
Bitcoin
83.062,63
5,85%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oramed Pharmaceuticals Inc (ORMP) Oramed Pharmaceuticals Inc (ORMP) Notizie

Oramed Pharmaceuticals Inc

ORMP
2,62
0,11 (4,38%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:28:20
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/3/202515:00PRNUSOramed Pharmaceuticals Issues Letter to Shareholders
03/3/202522:30EDGAR2Form 8-K - Current report
27/2/202523:00EDGAR2Form 8-K - Current report
13/2/202522:41EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
11/2/202522:35EDGAR2Form 8-K - Current report
11/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202515:15PRNUSOramed Announces Transformative Joint Venture to Accelerate..
22/1/202515:18EDGAR2Form 8-K - Current report
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202514:31EDGAR2Form 8-K - Current report
17/12/202422:55EDGAR2Form 8-K - Current report
08/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202422:01EDGAR2Form 8-K - Current report
08/10/202420:12EDGAR2Form 8-K - Current report
07/10/202416:00PRNUSOramed Pharmaceuticals Announces Restructuring of Scilex..
26/9/202422:05EDGAR2Form 8-K - Current report
23/9/202414:06EDGAR2Form 8-K - Current report
16/9/202422:42EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
02/8/202422:05EDGAR2Form 8-K - Current report
26/6/202415:05PRNUSOramed Letter to Shareholders
26/6/202415:00PRNUSOramed Pharmaceuticals Inc. Announces the Buy-Back of its..
20/6/202413:30EDGAR2Form DEF 14A - Other definitive proxy statements
10/6/202423:28EDGAR2Form 8-K - Current report
10/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202415:00EDGAR2Form 8-K - Current report
19/3/202414:00GLOBEScilex Holding Company Announces Repayment in Full of the..
Apertura: 2,43 Min: 2,42 Max: 2,66
Chiusura: 2,51

La tua Cronologia

NASDAQ
ORMP
Oramed Pharmaceuticals
BIT
P1NZ06
BNP Paribas Issuance
NASDAQ
WORX
SCWorx
BIT
NSCIT1309524
NV Bank Nederlandse Geme...
USOTC
ARMM
ARMM (CE)
NASDAQ
AAON
AAON
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci